In vitro and in silico evidence reveals anti-inflammatory effects of aryl-cyclohexanone, suggesting its therapeutic potential.
The results demonstrate that AD exerts significant anti-inflammatory and immunomodulatory effects, associated with CB2 receptor agonism, highlighting its potential as a promising candidate for developing therapeutic strategies for handling inflammatory diseases.
No takes yet. Share an insight, caveat, or question.
Lubschinski et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: